Device manufacturer, as written on reports
Bd Medical - Diabetes Care: medical device reports filed with FDA
8,110 reports name it as the manufacturer of the device involved, 2015–2025.
- 8,110
- reports naming it as manufacturer
- 0% of all MAUDE reports
- 1
- reports, 12 months to August 2026
- 27 in the 12 months before
- 96.4%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
8,110 medical device reports received by FDA give Bd Medical - Diabetes Care as the manufacturer of the device involved, 0% of the MAUDE database, from July 2015 to December 2025. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
1 reports arrived in the 12 months to August 2026, down 96% from 27 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (96.4%) and injury (3.5%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Bd Insulin Syringe With The Bd Ultra-Fine Needle | Syringe, piston | 859 | 0 | 0% |
| Bd Ultra-Fine Insulin Syringe | Syringe, piston | 764 | 0 | 0% |
| Relion Insulin Syringe | Syringe, piston | 480 | 0 | 0% |
| Bd Insulin Syringe With Bd Ultra-Fine Needle | Syringe, piston | 367 | 0 | 0% |
| Bd Insulin Syringes With Bd Ultra-Fine Needle | Syringe, piston | 231 | 0 | 0% |
| Syringe 0 3ml 29ga 1/2in 7bag 420cas Jp | Syringe, piston | 151 | 0 | 0% |
| Bd Plastipak Syringe | Syringe, piston | 16 | 25 | 0% |
| BD SafetyGlide | Needle, hypodermic, single lumen | 9 | 127 | 0% |
| Bd Eclipse Needle | Needle, hypodermic, single lumen | 6 | 1 | 0% |
| Bd Luer-Lok Syringe | Syringe, piston | 5 | 0 | 0% |
| BD Syringe | Syringe, piston | 5 | 117 | 0.4% |
| BD Luer-Lok | Syringe, piston | 4 | 333 | 0% |
| Bd Nano 2nd Gen Pen Needle | Needle, hypodermic, single lumen | 1 | 0 | 0% |
| Luer-Lok | Syringe, piston | 1 | 256 | 0% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| FMF | Syringe, piston | 7,274 | 89.7% |
| FMI | Needle, hypodermic, single lumen | 426 | 5.3% |
| MEG | Syringe, antistick | 286 | 3.5% |
| LKB | Pad, alcohol, device disinfectant | 91 | 1.1% |
| FPA | Set, administration, intravascular | 16 | 0.2% |
| JKA | Tubes, vials, systems, serum separators, blood collection | 12 | 0.1% |
| FOZ | Catheter, intravascular, therapeutic, short-term less than 30 days | 3 | 0% |
| FPK | Tubing, fluid delivery | 1 | 0% |
| GAA | Needle, aspiration and injection, disposable | 1 | 0% |
| JSM | Culture media, non-propagating transport | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Bd Medical - Diabetes Care reports
How many FDA device reports name Bd Medical - Diabetes Care as manufacturer?
8,110 reports through August 2026, 1 of them in the latest 12 months.
Which of its brands appear most often?
Bd Insulin Syringe With The Bd Ultra-Fine Needle (859), Bd Ultra-Fine Insulin Syringe (764), Relion Insulin Syringe (480), Bd Insulin Syringe With Bd Ultra-Fine Needle (367) and Bd Insulin Syringes With Bd Ultra-Fine Needle (231).
Which device types does it report on?
syringe, piston (89.7%), needle, hypodermic, single lumen (5.3%), syringe, antistick (3.5%) and pad, alcohol, device disinfectant (1.1%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.